Objective: To determine the antioxidant status of females with polycystic ovarian syndrome. Methods: Blood samples of 85 females (45 newly diagnosed polycystic ovarian syndrome patients and 40 apparently healthy subjects) between 25 and 45 years of age were obtained from Ekiti State University Teaching Hospital, Ado Ekiti, Ekiti State, Nigeria. Spectrophotometry was used to evaluate the plasma concentrations of malondialdehyde, vitamin A, C and E, reduced glutathione and activities of glutathione peroxidase, catalase and superoxide dismutase. Results: The concentrations of malondialdehyde and glutathione peroxidase activity significantly increased (P<0.05) in patients with polycystic ovarian syndrome compared with the healthy controls, while concentrations of reduced glutathione, vitamins A, C, E and activities of catalase and superoxide dismutase of patients with polycystic ovarian syndrome showed significant decrease (P<0.05) compared to the healthy controls. This study showed that oxidative stress may assume a role in the pathogenesis of polycystic ovarian syndrome. There were significant negative correlations between malondialdehyde and superoxide dismutase, catalase (P<0.01) and vitamin A (P<0.05), while there was a significant positive correlation (P<0.01) between malondialdehyde and glutathione peroxidase. In addition, vitamins A (P<0.05), C (P<0.01) and E (P<0.01) showed significant positive correlations with catalase antioxidant enzyme. However, vitamins C and E showed significant positive correlation (P<0.05) among each other.
Introduction
Polycystic ovary syndrome (PCOS) is a major commonly occurring endocrine disorder with prevalence of 5%-21% among reproductive-aged women [1] . PCOS is associated with a wide spectrum of complications in various parts of health, including reproductive, metabolic and psychological features. Several mechanisms suggested to contribute to the pathogenesis of PCOS include hormonal imbalance, resistance to insulin and genetic inheritance [1] . The primary cause of PCOS is multifactorial in origin, though hyperandrogenism, polycystic ovaries and oligoanovulation are common features in women with PCOS [2] .
Hyperandrogenism favors excess luteinizing hormone secretion in fetal life in hypothalamic-pituitary unit programming, bringing about the development of insulin resistance and abdominal obesity [3] . Also, disruption of ovulatory function (anovulation) in PCOS may result from both altered steroid negative feedback regulation of luteinizing hormone and the compensatory hyperinsulinemia caused by insulin resistance [4] . The Rotterdam
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Oxidative stress is an imbalance in the systemic expression of reactive oxygen species (ROS) and the inability of the biological system to readily detoxify or repair the reactive intermediates, thus producing peroxides and free radicals that might cause damages to cell components like lipids, DNA and proteins. An increase in oxidative stress, secondary to the free-radical mechanism, contributes to long term complications or development of metabolic diseases [6] . The utilization of antioxidants in the management of women with PCOS has generated great interests, though antioxidant supplementation has been reported to improve insulin sensitivity and other wellbeing undermining conditions [7] . A few features of PCOS, like increased androgen hormones, insulin resistance, abdominal adiposity and obesity, can induce oxidative stress in women with PCOS [8] . However, increased risk of cardiovascular disease, hypertension, central obesity and dyslipidemia, and insulin resistance may be caused by increased oxidative stress and decreased antioxidant ability [9, 10] .
Despite being one of the most well-known endocrine disorders in females, there is a dearth of information on the pathophysiology of PCOS. However, this research work estimates non-enzymatic antioxidants concentrations and enzymatic antioxidants activities in PCOS patients.
Materials and methods

Participants
A total of 45 women with PCOS, diagnosed for the first time and confirmed according to the 2004 Rotterdam Consensus Criteria, who attended Ekiti State University Teaching Hospital, Ado Ekiti, Ekiti State within the months of January and Febuary 2019, were enrolled as patients group [11] . Forty apparently healthy women were enrolled as the control group. However, haphazard sampling was employed for sampling in this study.
Participants' exclusion criteria included PCOS patients not
willing to be included in the study; Participants that were currently on medication and relatively health without PCOS; Unhealthy participants with diabetes, coronary artery disease, and other metabolic-related diseases. While participants' inclusion criterion included: Clinically diagnosed PCOS participants who were willing to participate or those who were relatively healthy without PCOS. The age range was 25-45 years old.
Some of the clinical manifestations of the PCOS in participants
involved this study included menstrual dysfunction (34, 85%), amenorrhea (6, 15%), infertility (24, 60%), hirsutism/acne (32, 80%), ultrasound evidence of cysts within the ovary (36, 90%) and high androgen concentration (26, 65%).
Ethical considerations
This study was approved by Ekiti State Teaching Hospital Ado Ekiti and Ekiti State University Ethics Committee (Ethical approval number: EKSUTH/A67/2019/04/008). Participants were provided with a proper understanding of the research work and written informed consent was provided by participants before collecting samples or any data. Relevant information about the participants' socio-demographic, anthropometric data and health history were collected by using questionnaires.
Collection of sample
Intravenous blood samples (10 mL) were collected into plain tubes at 10 days after the regular menstrual cycle of subjects by using a standard venipuncture technique. The serum of the collected blood samples was obtained by centrifugation at 3 000 rpm for 10 min using tabletop centrifuge (Scantroscan 60DV). The obtained serum was stored at -20 曟 for biochemical analysis. The prepared reaction mixture containing 0.5 mL serum sample, 0.5 mL phosphate buffer (0.1 M, pH 8.0) and 0.5 mL 24% trichloroacetic acid was incubated for 10 min at room temperature.
The incubated mixture was centrifuged at 2 000 rpm for 20 min by using tabletop centrifuge. Thiobarbituric acid (0.25 mL) of 0.33% in 20% acetic acid was added to 1.0 mL of the obtained supernatant and boiled for 1 h at 95 曟 . The resulting product (pink color) was cooled and the absorbance was measured by using spectrometer at 532 nm. The concentration of MDA was determined by using extinction coefficient of MDA, ε532 = 1.53 × 10 5 M -1 cm -1 .
Determination of superoxide dismutase (SOD) activity
The activity of SOD was determined spectrophotometrically by using the method described by Nur et al [13] . Into a 10 mL test tube, 200 μL of the serum sample was pipetted and 2.5 mL of 75 mM of Tris-HCl buffer (pH 8.2), 30 mM ethylenediaminetetraacetic acid and 300 μL of 2 mM of pyrogallol were also added. Absorbance was read at 420 nm for 3 min by using spectrophotometer. However, 50% inhibition of the rate of autooxidation of pyrogallol which was determined by change in absorbance/min at 420 nm was one unit of the enzyme activity. The SOD activity was expressed as units/mg protein.
Estimation of serum reduced glutathione (GSH) concentration
Nonenzymatic antioxidant, GSH concentration was estimated according to the method described by Abdel-Tawab et al [14] . Mixture 
Estimation glutathione peroxidase (GPx) activity
The activity of an enzymatic antioxidant, GPx, was assayed for using the method described by Viswanadha et al [15] . The prepared mixture used for the assay contained 250 μL sodium phosphate buffer (0.2 M, pH 8.0), 50 μL 10 mM sodium azide, 100 μL 4 mM GSH and 50 μL 2.5 mM H 2 O 2 . Serum (50 μL) was added to the assay mixture, and the total volume was made up to 1.0 mL with distilled water. This was incubated at 37 曟 for 3 min. To terminate the reaction, 250 μL of 10 % trichloroacetic acid was added, and then centrifuged at 3 000 rpm for 10 min to obtain the supernatant. Finally, 2.0 mL of disodium hydrogen phosphate (0.3 M) solution and 0.5 mL of 5,5'-dithiobis-(2-nitrobenzoic acid) were added. The absorbance of the resulting product was read at 412 nm spectrophotometrically. The expression of the enzyme's activity was in Units/mg protein.
Estimation of catalase activity
The activity of catalase, an enzymatic antioxidant was evaluated spectrophotometrically as the rate of disintegration of hydrogen peroxide according to the methods described by Kaya et al [16] . Into 
Determination of vitamin C (ascorbic acid) concentrations
The concentration of vitamin C was determined by using the method described by Subash-Babu et al [17] . Precipitation of 100 μL of the samples was done with 250 μL of 5% ice-cold tricarboxylic acid. The precipitated sample was centrifuged at 6 500 rpm for 20 min by using tabletop centrifuge. The mixture of one-tenth of 1.0 mL of supernatant with 0.2 mL of 2, 4 dinitrophenylhydrazine: thiourea: copper sulfate was done. The mixture was incubated for at 37 曟 for 3 h. Finally, 1.5 mL of ice-cold 65% H 2 SO 4 was added and thoroughly mixed. For another 30 min, the solution was kept at room temperature and the absorbance was read at 530 nm by using spectrophotometer. The values of vitamin C were expressed as μg/mg protein.
Estimation of vitamin-E (alpha-tocopherol) concentrations
The concentration of vitamin E (alpha-tocopherol) was determined spectrophotometrically by using the method of Okoduwa et al [18] . The n-hexane extract was prepared by adding 1.0 mL n-hexane and 2.0 mL water to the resulting sample solution and mixed. The mixture was allowed to rest for 10 min for phase separation. Drying of the hexane extract was done under nitrogen at 40 曟 and 0.2 mL methanol was used to re-dissolve the extract. Similar treatment done for the test samples were repeated with the tubes containing α-tocopherol standard. Also, the addition of 0.2 mL of 0.2% bathophenanthroline reagent to all the tubes including a reagent blank was done and the solution was thoroughly mixed. Exposure to direct sunlight was avoided from this point because the assay proceeded very fast. An addition of two-tenths of 1.0 mL of ferric chloride reagent was also done and test tubes were properly mixed by vortexing. Finally, 0.2 mL of orthophosphoric acid was added after 1 min and thorough mixing was done again. The absorbance of the resulting mixture was measured at 536 nm spectrophotometrically.
The value of vitamin E was expressed as mg/gm tissue.
Determination of vitamin A (beta-carotene bleaching assay) concentrations
The concentration of vitamin A was estimated by measuring the coupled autoxidation of β-carotene and linoleic acid using the method described by Hiroshi et al [19] . Table 2 showed the correlation between MDA level, enzymatic and nonenzymatic antioxidants. This study showed a significant negative correlation between MDA and SOD (r=-0.61, P<0.01), catalase 
Results
Levels of MDA, vitamins A, E, C and activities of catalase, GSH, GPx, SOD in PCOS patients
Correlation between antioxidant parameters of PCOS patients
Discussion
MDA is one of several by-products of lipid peroxidation process, a biomarker that provides an indication of the level of lipid peroxidation. Products generated from lipid peroxidation reactions have been widely employed as biomarkers for oxidative stress [20] .
This study shows that serum MDA concentration significantly increased in PCOS patients in comparison to the healthy controls. This is in line with the finding of Zhang et al who showed that the concentration of serum MDA in patients with PCOS was increased significantly when compared with the controls [21] . Also, alike result was gotten by Kuscu et al who ascribed increment in MDA to hyperglycemia and insulin resistance in PCOS [22] . Therefore, In the correlation between MDA, non-enzymatic and enzymatic antioxidants, this study shows a negative correlation between MDA, SOD, CAT and vitamin A in the group with PCOS. However, the mechanism of oxidative stress brought about by the imbalance in the formation of ROS and attenuation of anti-oxidative defense supports the negative correlation between the antioxidants parameters and MDA in PCOS patients. Therefore, this study suggests an increased lipid peroxidation and depletion of antioxidants leading to oxidative stress in patients with PCOS. This study also shows a significant positive correlation between MDA concentration and GPX activity, which implies that the increase in MDA concentration prompts an increment in GPX activity and this positive correlation may be to scavenge the effect of increased oxidative stress in PCOS patients.
However, vitamin C and E had a positive correlation which shows vitamin C and vitamin E interrelationship for scavenging free radicals. Vitamin C was reported to regenerate vitamin E by decreasing formed vitamin E radicals when oxygen radicals are scavenged by vitamin E [32] . However, vitamins C and E were reportedly found differently outside and inside the membranes respectively, in both liposomal membrane systems and inhomogeneous solutions, where the collaboration between vitamin C and vitamin E radicals was shown to occur and vitamin C plays a role of synergist [32] . Hence, maintenance of normal concentration of vitamin C is required to prevent oxidative stress. Finally, this study showed no statistically significant difference in both groups regarding age. Therefore, age was not affected in PCOS in this study.
In conclusion, both non-enzymatic and enzymatic antioxidants were implicated in this present study in patients with PCOS in comparison to the controls. However, according to this study, oxidative stress might play a significant role in the pathogenesis of PCOS. The 
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